Adverse events associated with medical cannabis reported within a centralized call center
Abstract Introduction: The use of medical cannabis products is expanding, yet real-world data on associated adverse events (AEs) remain limited.…
Paloma Lehfeldt
Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends
Abstract Background: Little is known about the distribution of cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) to patients participating in state medical…